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INTRODUCTION 
 The spinal cord is a vital and delicate structure of the central 
nervous system that is cushioned within the CSF, surrounded by the 
meningeal coverings, strong ligaments and encased within the protection 
of interlocking vertebral bones. Diseases of the spinal cord are termed as 
myelopathies, which can be secondary to trauma or may be due to non-
traumatic causes. Nontraumatic myelopathies are of two types: 
compressive myelopathies and non-compressive myelopathies. 
 Myelopathies commonly present with motor and sensory deficits 
along with sphincter disturbances. The clinical presentation and causes of 
compressive myelopathies characteristically differ from those of 
noncompressive myelopathies, although rare presentations in either 
category can mimic each other
1
 and pose a diagnostic dilemma to the 
astute clinician. The common causes of spinal cord compression are 
Pott‟s spine,fractures, infective abscess, arteriovenous malformations, 
spondylotic changes, spinal instability, tumours, multiple myeloma and 
metastases. The non-compressive myelopathies have wide and diverse 
etiologies like infective, inflammatory, demyelinating, vascular, 
hereditary causes or can be secondary to toxic exposure, metabolic 
disorders or nutritional deficiencies. 
The management strategies between compressive and non-
compressive myelopathies differ dramatically, as compressive lesions
2 
usually require urgent neurosurgical intervention and decompression of 
the spinal cord, whereas non compressive myelopathies
3
 are usually 
amenable to medical treatment itself. 
Myelopathies usually present with devastating neurological 
consequences like para-/quadriparesis, neurogenic bladder, decubitus 
ulcers, spasticity, etc which can impair the quality of life and 
independence of the affected individual. The sequelae of spinal cord 
disorders are myriad, with few diseases like subacute combined 
degeneration showing dramatic response to treatment, producing only a 
mild impact on the patient‟s daily life, whereas some cases of acute 
transverse myelitis or cord compression can hamper the vital functions of 
mobility, sensation, bladder and bowel control, making the patient 
completely dependent on their caregivers. Little information regarding 
the functional outcome of nontraumatic myelopathies as a whole is 
available in the current literature, although the outcome of few specific 
myelopathies like cervical spondylotic myelopathy and acute transverse 
myelitis has been described. 
 
REVIEW OF LITERATURE 
Gross anatomy of spinal cord: 
 The spinal cord is a vital component of the central nervous system 
which is essential not only for the control of voluntary movements of the 
limbs and truncal musculature but also functions to receive the sensory 
information from these regions and relays them to the brain. It also 
controls the functioning of the viscera and the blood vessels of the thorax, 
abdomen and pelvis.  
The spinal cord is a continuous nervous structure composed of gray 
and white matter and descends as continuation of the brain. The human 
spinal cord is composed of 8 cervical, 12 thoracic segments, 5 lumbar 
segments, 5 sacral segments and one coccygeal segment, thus having a 
total of 31 segments. These segments are described based on the pattern 
of spinal nerve origin from them. Usually one pair of spinal nerves 
emerges from each segment.  
There are normally two levels of spinal cord enlargements: cervical 
(brachial) enlargement which extends from C5 to T1 and the lumbosacral 
enlargement that extends from L2 to S2. The caudal end of the spinal 
cord tapers down to form the conus medullaris. 
The spinal cord is surrounded by cerebrospinal fluid and enclosed 
within the spinal meninges. The spinal meninges are the pia mater, 
arachnoid mater, and dura mater. External to the dura matter is the 
epidural space, which is filled with fat and lymphatic tissue, arterial 
vasculature and a venous plexus. The pia mater is tethered to the 
arachnoid and dura on each side of the spinal cord, between the ventral 
and dorsal spinal roots of each vertebral level, by a serrated tooth-like 
fibrous extension of the pia called the denticulate ligament.  
The spinal cord receives its blood supply from a single anterior 
spinal artery and two posterior spinal arteries. The anterior spinal artery 
originates from the vertebral artery whereas the posterior spinal arteries 
originate either from the vertebral artery or its posterior inferior 
cerebellar branch. The veins of the spinal cord form a surface plexus that 
drains superiorly into the cerebellar veins and cranial venous sinuses and 
through the intervertebral veins and external venous plexuses into the 
azygos system. 
 The typical cross-section of the spinal cord shows a 
centrally located gray matter with peripherally oriented white 
matter tracts. A central canal which is a remnant of the 
embryological ventricular system runs throughout the length of 
spinal cord and communicates with the fourth ventricle at the cranial 
end and with the terminal ventricle in the conus medullaris caudally. 
Internal architecture of spinal cord: 
Gray matter of the spinal cord: 
 The spinal cord gray matter is a „H‟-shaped complex structure 
composed of neuronal cell bodies, dendrites, axons, and neuroglial cells. 
The gray matter is grossly divided into dorsal and ventral horns with an 
intermediate zone between them. The Rexed lamina, determined on the 
basis of cytoarchitecture seen microscopically, divides the spinal gray 
matter into 10 regions. The first nine laminae are arranged from dorsal to 
ventral whereas the tenth lamina is the group of cells surrounding the 
central canal. Laminae 1-4 comprise the main cutaneous receptive 
regions; lamina 5 receives its afferents from the viscera, skin and muscles 
whereas lamina 6 mainly receives proprioceptive and some cutaneous 
afferents. Lamina 7 neurons are responsible for the regulation of posture 
and movement.  Lamina 8 contains cells which are the propriospinal 
interneurons. Lamina 9 contains clusters of large alpha motor neurons 
that supply the extrafusal fibers of the striated muscles involved in the 
movements of the axial skeleton and the limbs, along with gamma motor 
neurons innervating the intrafusal fibers present in muscle spindles. 
Lamina 10 is the area surrounding the central canal.  
Lateral spinal nucleus 
This is composed of a group of cells that lie ventral to the 
dorsolateral tip of the dorsal horn and is considered to project the 
received sensory information to themidbrain, thalamus, and 
hypothalamus. 
Lateral cervical nucleus 
It is a sensory nucleus lying lateral to the lateral spinal nucleus in 
upper cervical levels which projects to the cerebellum, midbrain, and 
thalamus. 
Onuf’s nucleus 
This is a distinct group of motor neurons in the caudal lumbosacral 
spinal cord seen in the ventrolateral portion of the ventral horn of the 
spinal cord. It supplies the perineal muscles and the anal and urethral 
sphincters.  
White matter of spinal cord 
The white matter of the spinal cord surrounds the gray matter all 
around except at the region where the dorsal horn touches the margin of 
the spinal cord. Although the white matter consists mostly of 
longitudinally running axons, it also contains glial cells. A large group of 
axons which are located in a given area is called a funiculus. Small 
bundles of axons that share common features within a funiculus are 
called as fasciculus. A group of nerve fibers having the same origin, 
course, termination and function is called a tract. The horns of gray 
matter divide the white matter into three columns or funiculi: dorsal, 
lateral and ventral. 
The dorsal column of white matter is primarily made up of the 
central processes of dorsal root ganglion cells. It is these large myelinated 
axons that form the main pathway conveying skin sensation as well as 
position sense (proprioception) from the limbs and trunk to the brain.  
The lateral and anterior columns contain the various ascending and 
descending fiber groups. The ascending tracts include the spinothalamic, 
the dorsal and ventral spinocerebellar, spino-olivary, spinotectal, 
spinoreticular, spinocervical, and spinovestibular tracts while the 
descending tracts include the corticospinal, vestibulospinal, reticulospinal 
and tectospinal tracts. There are propriospinal fibres also, that often lies 
very close to the gray matter and connects one spinal cord segment with 
another. The largest propriospinal pathways connect the brachial and 
lumbosacral enlargements which help in the coordination of limb 
movements. 
The sympathetic fibers are dispersed within the spinal cord and 
ultimately project to the interomediomedial (IMM) and 
interomediolateral (IML) neurons which lie within lamina VII extending 
from the T1 to L3 cord levels of the thoracolumbar cord. 
Thus, it is this complex architecture of the spinal cord and its tracts 
that results in the myriad of neurological manifestations in spinal cord 
diseases. 
Spinalcord syndromes: 
 The various manifestations in spinal cord diseases depend on the 
type of involvement which can be: 
1. Anterior cord syndrome 
i. Preservation of proprioception 
ii. Preservation of vibratory perception 
iii. Diminished or loss of pain and temperature sensation 
below lesion 
iv. Complete or incomplete motor loss 
2. Posterior cord syndrome 
i. Impaired vibration sense 
ii. Abnormal position sense 
iii. Loss of deep pressure perception 
iv. Diminished tactile localization 
v. Sensory gait ataxia 
vi. Tactile and postural hallucinations 
vii. Spared pain and temperature perception 
 Posterolateral cord syndrome 
i. Distal extremity paresthesia 
ii. Sensory ataxia 
iii. Hyperreflexia 
iv. Muscular spasticity 
v. Bilateral toe extensor signs (Babinski‟s) 
vi. Impaired proprioception and vibratory sense 
vii. Sparing of pain and temperature sensibility 
3. Central cord syndrome 
i. Bandlike thermoanesthesia or thermodysesthesia 
ii. Bandlike analgesia or hypoalgesia 
iii. Preservation of light touch 
iv. Dissociated sensory loss 
4. Anterior horn syndrome 
 Polio and post-polio syndrome 
i. Diffuse weakness (LMN) 
ii. Muscular atrophy 
iii. Reduced muscle tone 
iv. Muscle fasciculations 
v. Hyporeflexia or areflexia 
 Combined anterior horn cell and pyramidal tract disease 
(motor neuron disease) 
i. UMN: Spastic paresis, Extensor plantar responses, 
Hyperreflexia 
ii. LMN: Muscular atrophy, Flaccid paresis, 
Fasciculations 
5. Vascular syndromes 
 Anterior spinal artery syndrome 
i. Radicular and ascending leg pain 
ii. Sensory level for pain and temperature 
iii. Sudden progressive paraplegia 
iv. Flaccidity and areflexia (acute) 
v. Spasticity and hyperreflexia with Babinski‟s sign (late) 
vi. Sparing of touch, vibration, and temperature 
vii. Urinary and fecal incontinence (uncommon) 
 Posterior spinal artery syndrome 
i. Suspended global anesthesia 
ii. Regional tendon and cutaneous reflex loss 
iii. Dorsal column sensory level 
iv. Sparing of anterior cord functions 
 Radiculo-medullary syndrome 
 Central cord vascular syndrome 
6. Hemisection syndrome (Brown Sequard syndrome) 
i. Ipsilateral loss of vibratory perception 
ii. Segmental lower motor neuron signs at the level of the 
lesion 
iii. Ipsilateral loss of proprioception (position sense) 
(below level of lesion) 
iv. Contralateral loss of pain and temperature sensibility 
(one or two segments below level of lesions) 
v. Ipsilateral motor loss with spastic paresis 
vi. Inability to walk 
vii. Loss of normal bowel and bladder function 
7. Complete spinal cord transection (transverse myelopathy) 
It results in complete interruption of all ascending and 
descending tracts at the level of the lesion and leads to the 
loss of motor, sensory, autonomic, and reflex functions below 
that level. 
8. Conus medullaris syndrome 
i. Loss of bladder control 
ii. Loss of perianal muscle control 
iii. Absent bulbocavernosis reflex 
iv. Absent anal wink reflex 
v. Flaccid paresis of lower extremity 
9. Cervical medullary syndrome 
i. Respiratory insufficiency or arrest 
ii. Arterial hypotension 
iii. Varying degrees of tetraparesis 
iv. Facial sensory loss 
v. Greater arm than leg weakness 
10. Multifocal cord syndrome 
Compressive versus noncompressive myelopathy: 
The common clinical presentation in a compressive myelopathy is:  
 Pain which can manifest as root pain (radicular), vertebral 
pain, or funicular pain (central) 
 Asymmetric motor or sensory deficits 
 Ellsberg phenomenon (in case of cervical level lesions) 
There are three clinical stages of spinal cord compression:  
 radicular pain and segmental motor and sensory disruption 
 incomplete transection  
 complete cord transection. 
Compressive myelopathies are further divided into:  
1. Intramedullary compression 
Usually manifest with funicular pain, late UMN 
involvement, prominent and diffuse LMN signs, trophic 
changes, descending progression of paraesthesias, and 
early sphincter involvement. 
The common causes are: intramedullary neoplasms
4
, 
hematomyelia and syringomyelia. 
2. Extramedullary compression 
Usually present with radicular and vertebral pain, early 
UMN features, rarely LMN signs in segmental 
distribution, ascending sensory signs, and late bladder 
involvement. 
They are further classified as:  
a. Intradural 
The common causes are spondylosis
 5
, spondylolisthesis, 
facet joint arthropathies, ligamentum flavum hypertrophy, 
congenital spinal canal stenosis
6
, degenerative 
osteophytosis, intervertebral disc prolapse or bulge, nerve 
sheath tumors and meningiomas. 
b. Extradural 
Usually associated with prominent spinal tenderness. 
The common causes are: primary bone neoplasms, 
metastatic bone deposits and infections like Pott‟s spine, 
epidural abscess, etc. 
Non compressive myelopathies are due to: 
1. Vascular 7 
2. Infectious8 
a. Tropical spastic paraparesis (HTLV1 associated) 
b. HIV related vacuolar myelopathy 
c. Herpes related myelopathy 
d. Syphilitic myelitis 
e. Viral myelitis including poliomyelitis, etc. 
3.  Toxic  
a. Lathyrism 
b. Konzo 9 
c. Nitrous oxide toxicity 
4. Metabolic and nutritional 
a. Vitamin B12 deficiency10 
b. Folate deficiency 
c. Copper deficiency 
5. Secondary to inflammatory disorders 
a. Systemic lupus erythematosus, Behçet‟s disease, Sjogren‟s 
syndrome, and sarcoidosis
11
 
6. Para-/post infectious 
7. Paraneoplastic12 
8. Primary demyelinating disorders 
9. Radiation induced and  
10. Idiopathic causes 
The spectrum of nontraumatic myelopathies encompasses the 
above mentioned etiologies of myelopathies and can present as an acute 
onset illness, subacute course or as a chronic and progressive disease. 
In a prospective Indian study, Chaurasia et al
13
 described the 
etiological spectrum of 204 non-traumatic myelopathy patients presenting 
to a tertiary care hospital and noted that 61.7% of the cases had 
compressive etiology. Tuberculosis of spine was the most common cause 
of compressive myelopathy, followed by cervical spondylosis, whereas 
acute transverse myelitis and SACD were the common etiologies in the 
non-compressive group. 
Another Indian study on the MRI based diagnostic profile of 
compressive myelopathies described by Yadav et al
14
 showed that spinal 
tuberculosis was the commonest cause (24.6%) followed by spinal 
metastases (17.4%) and ossified posterior longitudinal ligament (7.8%). 
Prabhakar et al
 15
 had described the clinical and radiological profile 
of non-compressive myelopathy in fifty seven patients in which acute 
transverse myelitis (ATM) was noted to be the commonest cause. It was 
followed in frequency, by subacute combined degeneration secondary to 
vitamin B12 deficiency and primary progressive multiple sclerosis, in 
descending order. 
Das et al
16
 described a study on the profile of noncompressive 
myelopathy in eastern India where the presentation was acute in 48.78% 
patients, subacute in 8.53%, chronic in 32.92%. History of relapse and 
remission were seen in 9.75% patients.  Etiological diagnosis could be 
established in 71.95% of the cases whereas no aetiological factors could 
be found in the remaining patients. 
Alvarenga et al
17
 described the clinical course of 70 patients with 
noncompressive acute transverse myelitis, and noted that 59% of the 
cases were idiopathic, and those cases were also noted to have a 
favourable prognosis during long term neurological evaluation. 
Looti et al
18
 described 147 cases of nontraumatic myelopathies, 
determined on the basis of myelographic findings only, in a hospital 
based study in Cameroon and noted that majority of the cases were of 
compressive etiology, with metastases and infections like tuberculosis 
being the leading causes of compression. 
Owolabi et al
 19
 studied the profile and outcome of 98 Nigerian 
patients with non-traumatic paraplegia and noted that lower limb 
weakness was the commonest symptom and present in 100% of the cases. 
55 % had sensory deficits and another 55% manifested with sphincteric 
disturbances. 50% of cases had radicular pain and paresthesia was present 
in 38.4%.The commonest etiological factors were tuberculosis, transverse 
myelitis and metastatic spinal disease. 
Interesting, in a study by Modi et al
20
, describing hundred 
consecutive myelopathy cases in Africa, nearly half of the study 
population were found to be HIV positive, indicating the high prevalence 
of retroviral disease in that region as well as its contribution to the 
spectrum of spinal cord diseases occurring in that area. 
Moore et al
 21 
has described the causes of nontraumatic paraparesis 
and tetraparesis in a prospective study on 585 patients and noted that 
cervical spondylotic myelopathy was the most common cause, followed 
by extrinsic neoplastic or developmental tumour and multiple sclerosis 
respectively. 
In a hospital based survey on nontraumatic paraparesis, described 
by Watson
22
, the commonest etiology was disseminated sclerosis, 
followed by tumors and vascular lesions. These cases of nontraumatic 
paraplegia contributed to 30% of the new admissions to the spinal 
injuries unit. 
de Seze et al
23
 described the etiological and outcome profiles in 76 
patients with acute transverse myelitis and found that 43% were due to 
multiple sclerosis, 16.5% due to systemic diseases, 14% due to spinal 
cord infarcts, 6% due to parainfectious myelopathy, and 4% due to 
delayed radiation myelopathy. 16.5% patients had myelopathy for 
etiology could not be determined. Clinical outcome determined at 1 year 
showed good response in 88% of multiple sclerosis cases and poor 
outcome in 91% of spinal cord infarcts and 77% of systemic diseases. 
Cordonnier et al
24
 prospectively studied 55 patients with acute 
partial transverse myelitis and found that sensory symptoms, oligoclonal 
bands and brain MRI were factors that were predictive of the future 
conversion to clinically definite multiple sclerosis. 
In a retrospective study on 53 patients presenting with first episode 
of acute transverse myelitis described by Gajofatto et al 
25
, he noted that 
79% of patients were found to convert to multiple sclerosis on followup. 
The predictors of conversion in his study were the absence of a sensory 
level, absent bladder disturbances, neuroimaging abnormalities in the 
brain on MRI, involvement of spinal cord fewer than 3 vertebral 
segments, and abnormal somatosensory evoked potentials. 
A retrospective case-series of patients of acute transverse myelitis 
presenting to a university hospital in Pakisthan over a period of 14 years 
was reported by Kahloon et al
26
 where he noted that 60 % of the cases 
were idiopathic, 30% were parainfectious with maximum cases 
demonstrating a thoracic sensory level. More than 90% of cases 
presented with paraparesis and bladder dysfunction, and one fourth of the 
cases were found to be quadriparetic.  
Although vacuolar myelopathy is the most frequent cause of HIV 
associated paraparesis in individuals from developed countries, the 
spectrum of myelopathy associated with HIV differs widely in 
developing countries. Bhigjee et al
 27
 prospectively studied the spectrum 
of myelopathies in HIV seropositive South African patients and noted 
that only one of the thirty three patients had vacuolar myelopathy while 
the 36% of the patients had co-infection with HTLV-I, 18% had 
tuberculosis, 9% had zoster myelitis, and 6% had herpes simplex. This 
study showed that infective etiologies co-existing in HIV seropositive 
individuals was the most common cause of myelopathy in developing 
countries of Africa. 
A considerable number of patients with clinical picture of 
compressive myelopathy have a normal MRI which confounds the 
treating doctor. One of the surgically treatable causes of compressive 
myelopathy is spinal arteriovenous malformations which may have no 
neuroimaging abnormalities except for subtle flow voids or increased T2 
signal changes.    
Strom et al 
28 
reviewed 78 patients with unexplained myelopathy 
who had undergone spinal angiography in his institution and found spinal 
AVM as the cause of myelopathy in 22 patients (28.2%). Thus, spinal 
angiography is an important investigation that needs to be performed in 
patients with unexplained myelopathy to rule out MRI negative AVMs. 
Another interesting nontraumatic myelopathy frequently being 
reported in recent times is the surfer‟s myelopathy which is a form of 
nontraumatic spinal cord injury, exact pathophysiology of which is 
unclear but is probably secondary to ischemic insult to the cord due to 
dynamic compression, vasospasm,or thrombotic infarction of the spinal 
cord vasculature. 
Chang et al 
29 
has described the clinical characteristics of a large 
case series of surfer‟s myelopathy which is typically associated with 
young age, inexperience in surfing, hyperextension of lumbar spine, 
absence of trauma, and is clinically characterized by progressive 
paresthesias and weakness following a prodrome of backache. 
Tropical spastic paraparesis is a myeloneuropathy of 
noncompressive etiology being reported in the recent literature and 
widely associated with HTLV1 infection. One Indian study in Kerala by 
Oomman et al 
30
, however interesting noted that only one patient out of 
the twenty five patients of tropical spastic paraparesis was HTLV1 
positive by serology.    The authors had postulated that their case series 
could be representative of the previously described entity “seronegative 
spinal spastic paraparesis”. 
In a prospective study by Mckinley et al
31 
describing the 
epidemiology and functional outcome in nontraumatic myelopathy 
patients with quadriplegic and incomplete nontraumatic myelopathies had 
shorter in hospital length of stayas well as lower motor functional 
independent mobility (FIM) scoresat discharge and less change in FIM 
scores at follow-up.  
Cobo Calvo et al
 32
 studied the outcome of eighty seven patients 
with acute transverse myelitis and found that 13% of his patients with 
definite and possible idiopathic ATM converted to multiple sclerosis. He 
also noted that patients with bladder dysfunction at admission or 
longitudinally extending spinal cord lesions on MRI had a poor 
functional recovery on followup. 
Christensen et al
33
 studied the clinical features and long term 
outcome in acute transverse myelopathy and noted that thoracic 
myelopathy was the most common location. He also noted that while one 
third of the patients had a good outcome, another one- third had poor 
outcome with paraplegia, incontinence and severe sensory deficits, with 
the rest remaining static in their neurological status.  
Non traumatic spinal cord lesions are also associated with frequent 
medical complications during in- hospital rehabilitative care
 34
, with both 
disability and medical complications negatively affecting each other.  
A retrospective study on the histological diagnosis of 110 spinal 
cord lesions described in Pakisthan
 35
 showed tuberculosis as the leading 
cause of spinal cord pathologies followed by schwanommas. 
 Debette et al
36
 followed up 170 consecutive patients presenting 
with a first episode of acute and subacute noncompressive myelopathy 
which were defined by a symptom onset of less than 3 weeks and 
duration of more than 48 hours. The outcome beyond 2 years of initial 
diagnosis was assessed in which the death rate was noted to be8.8 %. The 
functional outcome was unfavourable in those patients who had initially 
severe symptoms, centrally located lesions on MRI, and when the 
etiology of disease was neuromyelitis optica or systemic diseases. It was 
noted that one-third of the patient‟s initial diagnosis differed from the 
final diagnosis at the end of 2 years of follow- up. More than 50% of the 
patients who had undetermined etiology were found to have multiple 
sclerosis on followup. 
Cervical compressive myelopathy is the often encountered 
compressive myelopathy which is amenable to surgical management. The 
various techniques employed for management of cervical myelopathy
 37 
are the posterior cervical techniques like laminectomy or laminoplasty 
and anterior surgical techniques like anterior cervical discectomy or 
anterior cervical corpectemy. 
Postoperative functional outcome in microsurgically treated 
intramedullary spinal cord compressive lesions were described by Ebner 
et al
38
 who noted that extended intramedullary lesions and poor pre-
operative neurological status were determinants of outcome in those 
cases. 
Schiff et al
39
 described the treatment outcome of forty cases of 
intramedullary spinal cord metastases, in which 35 patients had 
undergone radiotherapy and 5 underwent surgery. Only eleven patients 
had survived beyond 6 months. The median survival was noted to be 4 
months in patients receiving radiotherapy and 2 months for patients not 
receiving radiotherapy. 
 Putten et al
40
 studied the factors affecting functional outcome after 
in-patient rehabilitation in patients with nontraumatic myelopathies and 
found that patients with lower disability scores at admisison, early onset 
of rehabilitation and longer length of stay were associated with better 
functional outcomes.     
It is interesting to note that the etiologic spectrum of nontraumatic 
myelopathies varies among different populations and is 
epidemiologically different in the various regions of the world. Data from 
the developing countries show that maximum cases are related to 
degenerative age related changes as well as malignancies in the 
compressive myelopathies and demyelinating diseases as the common 
causes in noncompressive myelopathies. However, literature from the 
developing countries as well as those from India shows that infections, 
especially tuberculosis of the spine contribute to the major bulk of 
compressive myelopathies, but demyelinating diseases still continue to be 
the commonest etiology in noncompressive myelopathies. 
 
 
 
 
 
  
AIM OF THE STUDY 
 
1. To evaluate the clinical manifestations and aetiological profile 
of patients with nontraumatic myelopathy 
2. To study the functional status of patients with nontraumatic 
myelopathy at presentation and after 6 months 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
Study subjects:  
The study was conducted on patients attending the Neurology 
services at the Institute of Neurology, Madras Medical College & Rajiv 
Government General Hospital, Chennaifrom November 2012 to July 
2013. The approval from the Institutional Ethical Committee and 
informed consent of the patients participating in the study were obtained. 
Inclusion criteria: 
Hundred patients with non-traumatic myelopathy attending the 
Neurology services of Rajiv Gandhi Government General Hospital, 
Chennai were included in the study. 
Exclusion criteria: 
Patients with obvious trauma associated with the myelopathy or 
radiological evidence of traumatic etiology were excluded from the 
study as the management and outcome in these patients is affected by 
several in-hospital factors. 
 
 
 
Methodology: 
Each patient included in the study was methodically evaluated by 
obtaining a detailed history and performing complete neurological 
examination at presentation. This was recorded on a predesigned and 
structured proforma along with the routine investigations done as per 
standard protocol of the unit. 
Blood investigations which were done in all patients included 
complete hemogram, blood urea, serum creatinine, plasma glucose, liver 
function tests, CXR, ECG, HIV and VDRL.Nerve conduction studies, 
CSF analysis for cell count, cytology, protein, sugar as well as 
oligoclonal bands (in relevant cases), serum vitamin B12 levels (in 
relevant cases)and rheumatological investigations were done in all cases 
manifesting as noncompressive myelopathy.  
Magnetic Resonance Imaging (MRI) of the spine with or without 
contrast and brain and whole spine screening was done using 1.5 Tesla 
MRI on all patients with focus primarily on the site of spinal cord lesion 
localized clinically. The sequences used were: T1 and T2 sagittal, and T2 
axial and post gadolinium T1 contrast sections. CT of the spine was done 
in cases of suspected OPLL. 
The enrolled patients were clinically and radiologically classified as 
compressive or non-compressive myelopathy. Details regarding the 
treatment given, including medical and surgical management done during 
the hospital stay was also noted.  
Functional status of the patient using the Barthel index
41
 and 
modified Rankin scale
42
 was assessed at admission and at 6 months and 
recorded on the proforma with time-tolerance of a limit of +/-1 month on 
the day of assessment. 
The Barthel index (BI) is a 10- point scoring system used to assess 
the degree of independence of the individual with regards to activities of 
daily living. The items are divided into 10 items that focus on patient‟s 
ability at self-care (feeding, grooming, bathing, dressing, bowel and 
bladder care, and toilet use) and mobility (ambulation, transfers, and stair 
climbing). The patient‟s performance is judged either by direct 
observation of his performance or by asking the patient or caregiver‟s 
regarding his degree of functional independence.  The total score ranges 
from 0 to 100, with higher scores indicating greater functional 
independence. The lowest score is 0 which represents a totally dependent 
and bedridden state. 
The modified Rankin scale (mRS) is another scale primarily used to 
assess the outcome of stroke patients. The mRSscale measures gross 
independence of the individual instead of assessing the performance of 
specific tasks.It incorporates assessment of both the mental and physical 
adaptations of the individuals to their neurological deficits. The scale 
consists of scores ranging from 0 to 6, with 0 corresponding to no 
symptoms, 5 corresponding to severe disability and 6 to dead status. 
Statistical considerations: 
The entire data gathered on the patients with nontraumatic 
myelopathy was tabulated and analysed using statistical software SPSS 
version 17.0. Chi square testanalysis was used for comparison between 
the two groups of compressive and noncompressive myelopathy. 
Multivariate Analysis of variance model (MANOVA) using generalized 
linear models approach was used to assess the significance of association 
of clinical and radiological factors in patients with nontraumatic 
myelopathy with the initial functional status at presentation and  6- month  
functional outcome (determined using Barthel index and mRS). All „p‟- 
value less than 0.05 were considered statistically significant. 
 
RESULTS 
 Hundred patients with nontraumatic myelopathy were included in 
the study. Of the hundred cases, forty eight patients (48%) were found to 
have non compressive myelopathy and fifty two (52%) patients had 
compressive myelopathy.  
Demographic profilein nontraumatic myelopathy 
The mean age of the hundred patients with nontraumatic 
myelopathy was 40.78 + 16.56 years with age ranging from 14 to 70 
years. Of them, 59 % were males and the rest 41% were females. All 
patients belonged to a low socioeconomic status.  
 
Table 1: Age distribution in nontraumatic myelopathy 
 
Nontraumatic 
Myelopathy 
Frequency Percent Valid Percent 
Cumulative 
Percent 
 11-20 years 18 18.0 18.0 18.0 
21-30 years 13 13.0 13.0 31.0 
31-40 years 16 16.0 16.0 47.0 
41-50 years 21 21.0 21.0 68.0 
51-60 years 20 20.0 20.0 88.0 
61-70 years 12 12.0 12.0 100.0 
Total 100 100.0 100.0  
 
 
Fig 1: Sex distribution in nontraumatic myelopathy   
 
Clinical characteristics in nontraumatic myelopathy 
 48 patients with nontraumatic myelopathy had paraparesis at 
presentation whereas 46% were quadriparetic. One patient presented with 
brachial monoparesis. 4 patients did not manifest with any weakness and 
had presented to the hospital with non-motor complaints only. 
Table 2: Pattern of weakness at presentation 
Weakness Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Asymptomatic 4 4.0 4.0 4.0 
Crural monoparesis 1 1.0 1.0 5.0 
Paraparesis 48 48.0 48.0 53.0 
Quadriparesis 46 46.0 46.0 99.0 
Brachial monoparesis 1 1.0 1.0 100.0 
Total 100 100.0 100.0  
 
59%
41%
Sex distribution
Males 
Females
Onset of illness was acute in 22 % patients. Subacute onset was 
noted in another 20 % whereas 58 patients had a chronic and progressive 
course prior to presenting to the hospital. 
Fig 2: Onset of illness in nontraumatic myelopathy 
 
95% of the patients had both proximal and distal limb weakness 
and 2 patients presented with distal predominant weakness in addition to 
clinical evidence of myelopathy. The presenting motor weakness was 
symmetric in 46% of patients and asymmetric in 48% of the patients.  
Of the hundred cases, sensory complaints were present in 69 
patients. In those patients, 44 patients presented with a sensory level, 10 
patients manifested with glove and stocking type of sensory loss, 8 
patients had radicular pattern of sensory loss, 5 patients manifested with 
diffuse funicular pain, and only 2 patients had hemisensory loss. 
Fig 3: Sensory complaints  
 
Bowel disturbances were present in 11 % of the patients with only 
one patient manifesting as bowel incontinence whereas the rest of the 
patients with bowel disturbances had constipation as their predominant 
bowel related complaint. 
In contrast, urinary sphincter disturbances were seen in a higher 
number of the patients with nontraumatic myelopathy. 14% presented 
with acute urinary retention, 34 % had complaints of urgency, 5 % had 
hesitancy, and only one patient had urinary incontinence at presentation. 
Table 3: Spectrum ofbladder related complaints 
Bladder 
symptoms Frequency Percent Valid Percent 
Cumulative 
Percent 
None 44 44.0 44.0 44.0 
Urgency 34 34.0 34.0 78.0 
Incontinence 2 2.0 2.0 80.0 
Retention 14 14.0 14.0 94.0 
Hesitancy 5 5.0 5.0 99.0 
Frequency 1 1.0 1.0 100.0 
Total 100 100.0 100.0  
 
Only three patients manifested with speech disturbances. One had a 
spastic quality of speech and the other two had cerebellar pattern. 
Visual symptoms were present in 9% of patients with 7 patients 
having acute loss of vision and two patients presenting with progressive 
blurring of vision. All the patients with visual complaints belonged to the 
non-compressive group. None of the recruited patients had any symptoms 
pertaining to auditory involvement, although one patient was found to 
have bilateral sensori-neural hearing loss after clinical examination and 
audiological assessment.  
 Neck pain was the most frequent form of vertebral complaint 
manifesting in 30% of patients, followed by low back ache which was 
seen in 14% of the nontraumatic myelopathy patients. 
Fig 4: Vertebral symptoms reported by patients 
 
The patients reported a history of trauma in 4% of total cases, 
whereas three patients had a past history of similar episodes prior to the 
current presentation. 3 patients had co-existing fever, 2 patients had 
anemia with past history of prior blood transfusions, and one patient had 
significant cachexia. 
Co-morbid conditions were present in 19 % of cases which were 
diabetes mellitus (3%), systemic hypertension (7 %), tuberculosis (4 %), 
HIV (3%), and hyperlipidemia (1 %). 
53%
30%
14%
3%
None
Neck pain
Low back ache 
Radicular pain
21 % reported history of alcohol abuse and 7% had the habit of 
chronic smoking. 4 % also reported exposure to high risk sexual partners. 
Only 2% had significant family history. Both were noted to be cases of 
hereditary spastic paraparesis.  
All patients had Glasgow Coma scale (GCS) scores greater than 8 
at admission. None presented with any alteration of sensorium. Only one 
patient who was severely vitamin B12 deficient presented with dementia. 
Examination revealed optic neuropathy in 10% of cases, with all 
cases belonging to non-compressive group. One patient was noted to 
have bilateral sensorineural hearing loss. Wasting with reduced bulk of 
musculature was seen in 4% of cases. Spasticity was noted in 74% of 
patients while 17% were hypotonic. It was also seen that 51% of patients 
had a positive Romberg sign, 10% had peripheral neuropathy, 10% had 
radicular involvement, and 7% had cerebellar signs. 
Investigative and etiologic profile in nontraumatic myelopathy 
 Investigations showed anemia in 19% of the nontraumatic 
myelopathy cases and one patient manifested with bicytopenia. Other 
routine blood investigations did not reveal any statistically significant 
abnormality. Four patients had evidence of tuberculosis on radiologic 
evaluation and another three were reactive for HIV – ELISA. None of the 
patients with HIV had co-existing tuberculosis. Syphilis serology by 
VDRL technique was non-reactive in all patients. CSF examination was 
done in all 48 patients with noncompressive myelopathy in which 9 
patients showed elevated protein levels and one was oligoclonal band 
positive.  
Fig 5: MRI findings in nontraumatic myelopathy 
 
MRI spine was abnormal in 76% of the total patients. All the 
patients with normal MRI picture belonged to the noncompressive 
myelopathy group. MRI spine showed no lesions in 24 patients, cervical 
cord lesions in 44 patients, dorsal cord lesions in 23 patients. Analysis of 
the distribution of lesions in the MRI positive individuals showed 44 
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patients (57.89 %) having the pathology in the cervical cord. In those 
patients with cervical cord lesions, majority (84.1%) belonged to the 
compressive myelopathy group. Longitudinally extending transverse 
myelitis (LETM) lesions were noted in 11% of patients. All patients with 
LETM belonged to the noncompressive group only. 
Out of the 100 patients with nontraumatic myelopathy, 59 patients 
received medical management and 41 patients underwent surgery. All 
those who underwent surgery had compressive myelopathy. 11 % of the 
nontraumatic myelopathy patients who had compressive myelopathy 
received conservative medical management due to their lack of fitness for 
surgery or their unwillingness to undergo surgical intervention. Twenty 
eight out of 48 patients were managed with steroids in the 
noncompressive myelopathy group. Demyelinating disorders like acute 
transverse myelitis, multiple sclerosis and NMO spectrum disorders were 
the common etiologies requiring use of steroids. 
Functional outcome in nontraumatic myelopathy 
The mean Barthel index score at initial presentation was 51.15 + 
19.67 with a range of 5 to 100. The corresponding mean mRS score was 
3.29+0.81 with values ranging between 0 and 5 in the patients with 
nontraumatic myelopathy. None of the patients enrolled in the study died 
during the hospital stay.  
Fig 6: Functional outcome at 6 months  
 
16 patients were lost to followup at the end of 6 months. Of them, 4 
patients belonged to noncompressive myelopathy group and 12 patients 
belonged to compressive myelopathy group. Evaulation at 6 months 
revealed that average Barthel index was 55.77+ 19.56 and average mRS 
score was 3.02+ 0.86. At the end of 6 months, it was noted that 40 % and 
25 % patients had improved in their Barthel index and mRS scores 
respectively, whereas 36 % and 56 % of the patients had remained static 
in their Barthel index and mRS scores respectively. 8 % had 
paradoxically worsened Barthel index scores. 
Compressive myelopathy versus noncompressive 
myelopathy: 
 The mean age of patients with non compressive myelopathy was 
34.27+ 15.66 years whereas the mean age was 46.78+ 15.12 years. 
Fig 7: Age spectrum in both groups 
 
 Out of the patients with nontraumatic myelopathy, 59% were 
males. Of the males, 55.9% belonged to the compressive myelopathy 
group. Interestingly, 53.7% of the females belonged to the 
noncompressive group which was not statistically significant. 
Table 4: Sex distribution in both groups 
   Group   
   Non 
compressive Compressive Total p- value 
Sex Male Count 26 33 59  
% within Sex 44.1% 55.9% 100.0%  
0.345 Female Count 22 19 41 
% within Sex 53.7% 46.3% 100.0%  
 Total Count 48 52 100  
% within Sex 48.0% 52.0% 100.0%  
 
 The onset was acute in 22 patients, all (100%) of them belonging to 
the non compressive group, whereas chronic course of illness was noted 
in 58 patients, with 18 patients (31%) belonging to the noncompressive 
group and the rest 69% (40 patients) in compressive group. The 
difference between the two groups was statistically significant (p<0.05).   
Table 5: Onset of illness in both groups 
 Group   
NCM CM Total p- value 
Onset Acute Count 
%  
22 0 22  
 
 
<0.01** 
100.0% .0% 100.0% 
Sub-
acute 
Count 
%  
8 12 20 
40.0% 60.0% 100.0% 
Chronic Count 
%  
18 40 58 
31.0% 69.0% 100.0% 
 Total Count 
%  
48 52 100  
48.0% 52.0% 100.0% 
*- p<0.05; **- p<0.01 
Comparing the pattern of weakness between compressive and non 
compressive revealed that 35 patients (72.9 %) of the total 48 paraparetic 
patients belonged to the non-compressive group, whereas 38 (82.6%) of 
the 46 patients with quadriparesis belonged to the compressive 
myelopathy group, and the difference between the two groups was 
alsostatistically significant (p<0.05).  
The varied etiological spectrum in compressive and non-
compressive myelopathies is elaborated in the Table 5 and Table 6. 
Table 5:Aetiologic diagnosis in noncompressive myelopathy 
Non compressive myelopathy Frequency Percent 
Acute transverse myelitis  23 47. 91 
-Idiopathic ATM 7 14.58 
-MS Spectrum 5 10.42 
-NMO Spectrum 11 22.91 
HIV related 3 6.25 
B12 deficiency 6 12.5 
HSP 8 16.66 
TB Myeloradiculitis 1 2.09 
Hirayama 1 2.09 
Unclassified 6 12.5 
   
Total 48 100.0 
Table 6:Aetiologic diagnosis in compressive myelopathy 
Compressive myelopathy  Frequency Percent 
Cervical spondylotic myelopathy 29 55.76 
-Spondylotic cervical canal stenosis 17 32.69 
-IVDP 6 11.54 
-OPLL 4 7.69 
-Hypertropic ligamentum flavum 2 3.84 
Pott‟s spine 3 5.78 
CVJ anomaly 1 1.92 
Atlantoaxial dislocation 1 1.92 
C1-C2 subluxation 3 5.78 
Extramedullary SOL 7 13.46 
Intramedullary SOL 6 11.54 
Dural AVM 1 1.92 
Metastasis 1 1.92 
   
Total 52 100 
 
The compressive and non-compressive myelopathy patients in our 
study showed differences in clinical presentation as well as location of 
radiological lesion including muscle tone at presentation, pattern of 
weakness and bladder disturbances between the two groups showed 
statistical significance.94.1% of patients with hypotonia belonged to the 
noncompressive myelopathy group whereas 67.6% of patients with 
spasticity belonged to the compressive group, the difference of which 
showed statistical significance (p<0.01). Symmetric weakness was 
significantly seen more frequently in noncompressive myelopathy. 
Fig 8: Sensory complaints between both groups 
 
Table 7: Spectrum of bladder complaints in both groups 
   Group 
Total p- value  Bladder disturbances  NCM CM 
 None Count (%) 21 23 44  
Percent 47.7% 52.3% 100.0%  
 
 
 
 
0.01* 
Urgency Count 9 25 34 
Percent 26.5% 73.5% 100.0% 
Incontinence Count 1 1 2 
Percent 50.0% 50.0% 100.0% 
Retention Count 12 2 14 
Percent 85.7% 14.3% 100.0% 
Hesitancy Count 5 0 5 
Percent 100.0% 0% 100.0% 
Frequency Count 0 1 1 
Percent .0% 100.0% 100.0% 
 Total Count 48 52 100  
Percent  48.0% 52.0% 100.0%  
*- p<0.05; **- p<0.01 
 The location of MRI lesion in compressive and noncompressive 
myelopathy also showed statistical significance with cervical lesions 
dominating compressive myelopathy and dorsal cord lesions more 
commonly seen in non-compressive myelopathy. 
Table 8: MRI lesion location between two groups 
 
  Group 
Total p- value MRI lesion location  NCM CM 
Cervical 
Dorsal 
Cervicodorsal 
Dorsolumbar 
Normal 
7 37 44  
11 12 23  
4 1 5 <0.01** 
2 2 4  
24 0 24  
Total 48 52 100  
*- p<0.05; **- p<0.01 
Fig 9: MRI lesion location between two groups 
 
Functional outcome and predictors: 
 The functional outcome in patients with nontraumatic myelopathy 
assessed using Barthel index and modified Rankin scale was done on the 
84 followed-up patients at the end of 6 months, which are depicted below 
in Fig 9 and Fig 10. 
Fig 9: Functional outcome of Barthel index at 6 months  
 
Fig 10: Functional outcome of modified Rankinscale at 6 months 
 
Table 8: Multivariate analysis on impact of specific factors on initial 
Barthel index and mRS 
 
Effect Value F 
Hypothesis 
df 
Error  
df P value 
Intercept Pillai's Trace .902 362.067 2.000 79.000 .000 
Wilks' Lambda .098 362.067 2.000 79.000 .000 
Hotelling's Trace 9.166 362.067 2.000 79.000 .000 
Roy's Largest Root 9.166 362.067 2.000 79.000 .000 
Acute onset Pillai's Trace .019 .785 2.000 79.000 .459 
Wilks' Lambda .981 .785 2.000 79.000 .459 
Hotelling's Trace .020 .785 2.000 79.000 .459 
Roy's Largest Root .020 .785 2.000 79.000 .459 
Abnormal MRI 
Spine 
Pillai's Trace .054 2.241 2.000 79.000 .113 
Wilks' Lambda .946 2.241 2.000 79.000 .113 
Hotelling's Trace .057 2.241 2.000 79.000 .113 
Roy's Largest Root .057 2.241 2.000 79.000 .113 
Presence of 
sensory level 
Pillai's Trace .000 .001 2.000 79.000 .999 
Wilks' Lambda 1.000 .001 2.000 79.000 .999 
Hotelling's Trace .000 .001 2.000 79.000 .999 
Roy's Largest Root .000 .001 2.000 79.000 .999 
Paraparesis Pillai's Trace .064 2.679 2.000 79.000 .075 
Wilks' Lambda .936 2.679 2.000 79.000 .075 
Hotelling's Trace .068 2.679 2.000 79.000 .075 
Roy's Largest Root .068 2.679 2.000 79.000 .075 
Quadriparesis Pillai's Trace .228 11.689 2.000 79.000 .000** 
Wilks' Lambda .772 11.689 2.000 79.000 .000** 
Hotelling's Trace .296 11.689 2.000 79.000 .000** 
Roy's Largest Root .296 11.689 2.000 79.000 .000** 
MRI lesion in 
cervical cord 
Pillai's Trace .034 1.379 2.000 79.000 .258 
Wilks' Lambda .966 1.379 2.000 79.000 .258 
Hotelling's Trace .035 1.379 2.000 79.000 .258 
Roy's Largest Root .035 1.379 2.000 79.000 .258 
Bladder 
disturbances 
Pillai's Trace .348 4.215 8.000 160.000 .000** 
Wilks' Lambda .655 4.656 8.000 158.000 .000** 
Hotelling's Trace .522 5.094 8.000 156.000 .000** 
Roy's Largest Root .514 10.272 4.000 80.000 .000** 
Diagnosis of 
ATM or 
cervical 
spondylosis 
Pillai's Trace .054 1.107 4.000 160.000 .355 
Wilks' Lambda .946 1.108 4.000 158.000 .355 
Hotelling's Trace .057 1.108 4.000 156.000 .355 
Roy's Largest Root .056 2.252 2.000 80.000 .112 
LETM Pillai's Trace .116 5.165 2.000 79.000 .008** 
Wilks' Lambda .884 5.165 2.000 79.000 .008** 
Hotelling's Trace .131 5.165 2.000 79.000 .008** 
Roy's Largest Root .131 5.165 2.000 79.000 .008** 
Treatment 
Modality 
Pillai's Trace .082 1.714 4.000 160.000 .149 
Wilks' Lambda .918 1.729 4.000 158.000 .146 
Hotelling's Trace .089 1.743 4.000 156.000 .143 
Roy's Largest Root .088 3.532 2.000 80.000 .034 
Group Pillai's Trace .000  .000 .000 . 
Wilks' Lambda 1.000  .000 79.500 . 
Hotelling's Trace .000  .000 2.000 . 
Roy's Largest Root .000 .000 2.000 78.000 1.000 
*- p<0.05; **- p<0.01 
 The MANOVA model was used to assess the impact of several 
disease related factors on the functional status at presentation which 
showed that there was a statistically significant difference in the Barthel 
Index and mRS between the groups who have and do not have bladder 
disturbance, quadriparesis or LETM. No statistically significant 
differences in the BI and mRSwere noted in the other factors. 
 
Table 9: Multivariate analysis on impact of specific factors on 6-
month Barthel index and mRS 
 
Effect Value F 
Hypothesis 
df Error df P value 
Intercept Pillai's Trace .890 255.642 2.000 63.000 .000 
Wilks' Lambda .110 255.642 2.000 63.000 .000 
Hotelling's Trace 8.116 255.642 2.000 63.000 .000 
Roy's Largest Root 8.116 255.642 2.000 63.000 .000 
Acuteonset Pillai's Trace .011 .364 2.000 63.000 .697 
Wilks' Lambda .989 .364 2.000 63.000 .697 
Hotelling's Trace .012 .364 2.000 63.000 .697 
Roy's Largest Root .012 .364 2.000 63.000 .697 
Abnormal 
MRISpine 
Pillai's Trace .015 .466 2.000 63.000 .630 
Wilks' Lambda .985 .466 2.000 63.000 .630 
Hotelling's Trace .015 .466 2.000 63.000 .630 
Roy's Largest Root .015 .466 2.000 63.000 .630 
Presenceofsens
orylevel 
Pillai's Trace .025 .806 2.000 63.000 .451 
Wilks' Lambda .975 .806 2.000 63.000 .451 
Hotelling's Trace .026 .806 2.000 63.000 .451 
Roy's Largest Root .026 .806 2.000 63.000 .451 
Paraparesis Pillai's Trace .014 .454 2.000 63.000 .637 
Wilks' Lambda .986 .454 2.000 63.000 .637 
Hotelling's Trace .014 .454 2.000 63.000 .637 
Roy's Largest Root .014 .454 2.000 63.000 .637 
Quadriparesis Pillai's Trace .102 3.589 2.000 63.000 .033* 
Wilks' Lambda .898 3.589 2.000 63.000 .033* 
Hotelling's Trace .114 3.589 2.000 63.000 .033* 
Roy's Largest Root .114 3.589 2.000 63.000 .033* 
MRIlesion in 
cervical cord 
Pillai's Trace .005 .168 2.000 63.000 .846 
Wilks' Lambda .995 .168 2.000 63.000 .846 
Hotelling's Trace .005 .168 2.000 63.000 .846 
Roy's Largest Root .005 .168 2.000 63.000 .846 
Bladder 
disturbances 
Pillai's Trace .339 3.268 8.000 128.000 .002** 
Wilks' Lambda .671 3.483 8.000 126.000 .001** 
Hotelling's Trace .477 3.694 8.000 124.000 .001** 
Roy's Largest Root .444 7.097 4.000 64.000 .000** 
Diagnosis of 
ATM or 
cervical 
spondylosis 
Pillai's Trace .091 1.528 4.000 128.000 .198 
Wilks' Lambda .910 1.527 4.000 126.000 .198 
Hotelling's Trace .098 1.525 4.000 124.000 .199 
Roy's Largest Root .088 2.829 2.000 64.000 .066 
LETM Pillai's Trace .023 .746 2.000 63.000 .479 
Wilks' Lambda .977 .746 2.000 63.000 .479 
Hotelling's Trace .024 .746 2.000 63.000 .479 
Roy's Largest Root .024 .746 2.000 63.000 .479 
Treatment 
Modality 
Pillai's Trace .038 .626 4.000 128.000 .644 
Wilks' Lambda .962 .619 4.000 126.000 .650 
Hotelling's Trace .039 .611 4.000 124.000 .656 
Roy's Largest Root .031 .994 2.000 64.000 .376 
Group Pillai's Trace .000  .000 .000 . 
Wilks' Lambda 1.000  .000 63.500 . 
Hotelling's Trace .000  .000 2.000 . 
Roy's Largest Root .000 .000 2.000 62.000 1.000 
*- p<0.05; **- p<0.01 
The MANOVA model used to assess the impact of the same 
disease related factors on the functional outcome at 6 months showed that 
there was a statistically significant difference in the Barthel Index and 
mRS between the groups who have and do not have bladder disturbance 
and quadriparesis. No statistically significant differences in the BI and 
mRSwere noted in the other factors including LETM which had initially 
shown significance for functional status at presentation. 
DISCUSSION 
 Patients with nontraumatic myelopathy are broadly subdivided as 
compressive myelopathy and noncompressive myelopathy based on the 
evidence of clinical and neuroradiological features of any spinal cord 
lesion (extrinsic or intrinsic) causing compression. The clinical features 
as well as the etiological spectrum in either group are known to differ in 
varying levels in the prior studies. There is scanty information on the 
functional outcome of patients with nontraumatic myelopathy as a whole 
group in the current literature.This study was undertaken to study the 
clinical spectrum of patients with nontraumatic myelopathy and assess 
their functional outcome at 6 months.  
Out of the previous studies on nontraumatic myelopathies, only one 
study from India assesses the aetiologic spectrum in nontraumatic 
myelopathy, examining them as a whole group. According to Chaurasia 
et al 
13
, the most common etiology of compressive myelopathy was 
tuberculosis comprising 35.71% of the group, which is in contrast to our 
findings which shows that majority of compressive myelopathy was 
contributed by cervical degenerative spondylotic myelopathy (55.76%) 
alone. Tuberculosis as a cause of compressive myelopathy was seen in 
only 5.78% of the compressive myelopathy patients.  In the 
noncompressive group, Chaurasia et al
13
 described that 21.79% of cases 
were due to acute transverse myelitis whereas our findings show that 
acute transverse myelitis comprised 47.91% of the cases.  
Another Indian study by Yadav et al 
14
 describing the spectrum of 
compressive myelopathies also showed that spinal tuberculosis was the 
commonest cause (24.6%) followed by spinal metastases (17.4%). 
Ossified posterior longitudinal ligament (OPLL) constituted 7.8% of the 
total cases which correlated with our study population which had OPLL 
in 7.69% of the cases.  
Prabhakar et al 
15
 reported the clinical and radiological findings in 
57 Indian patients with noncompressive myelopathy having a mean age 
of 34.45 years which was similar demographically to our population 
whose mean age was 34.27 years. He reported that 81% were 
symmetrical with 54.38 % of the cases being acute transverse myelitis. 
12.28 % of their patients were diagnosed to have vitamin B12 deficiency 
which was similar to the 12.5% of vitamin B12 deficiency in our study 
population.  
A hospital based study on nontraumatic myelopathies by Lekoubou 
Looti et al
18
in Cameroon showed similarities in the demographic profile 
of their study cases with our patients. However, 83.7% of their patients 
manifested with paraparesis and only 16.3% with quadriparesis at 
presentation, which is quite in contrast to our findings of nearly equal 
cases of paraparesis (48%) and quadriparesis (46%). Also, 89.8% of their 
cases had a sensory level on examination as against our study group who 
manifested with a definite sensory level in only 44% of the cases. While 
80.7% of their study subjects had sphincter disturbances, only 56% of our 
patients reported bladder related complaints.  The most common cause of 
nontraumatic myelopathy in their cohort was primary or secondary spinal 
tumors which accounted for 24.5% of the total cases whereas our study 
had maximum proportion of cases of cervical spondylotic myelopathy.  
A Nigerian study on the profile of nontraumatic paraplegia
19
 also 
reported tuberculosis as the commonest causes accounting to 44.7% of 
the patients. Also 14.1% of their patients were found to be positive in 
HIV screening, whereas our study showed 3% seropositivity for HIV in 
the nontraumatic myelopathy patients. Interestingly, Modi et al 
20
 who 
assessed the prevalence of HIV in nontraumatic myelopathy in HIV 
endemic South African hospital noted a high prevalence of HIV in 
51.54% of the admitted cases. 
Das et al 
16
 who studied the profile of non-compressive myelopathy in 
Eastern India showed acute presentation in 48.78% and chronic presentation in 
32.92%. Etiological diagnosis was established in71.95% patients and 
transverse myelitis was diagnosed in 29.26%.  
Western studies have shown cervical spondylotic myelopathy as the 
commonest cause of compressive myelopathy. Moore et al 
21
 who studied 585 
patients with spastic parparesis and tetraparesis found that spondylotic 
myelopathy was the commonest accounting for 24 % of the total cases. Most 
of his cases were of compressive etiology and multiple sclerosis was detected 
in 9.1 % of the cases. He reported arteriovenous malformation (AVM) in 0.9% 
of his cases which parallels our study cohort who had AVM in 1% of the 
population. 
Studies on functional outcome in nontraumatic myelopathy are not 
available in the current literature, although outcome assesement in 
compressive and noncompressive myelopathy of specific etiologies have 
been described.   
Christensen et al
33
 described the longterm follow-up of 29 cases of 
acute transverse myelopathy and noted that one third had a good 
outcome, while one third had poor outcome. Back-pain and signs of 
spinal shock were found to indicate worse outcome in his study. This is in 
contrast to our study in which mRS showed improvement in 25 % and 
worsening in 3%, whereas Barthel index showed improvement in 40 % 
and worsening in 8% of the patients.  
One interesting study by Ebner et al
38
, has shown that patients 
diagnosed to have extended intramedullary lesions have a worse 
neurological status in the perioperative as well as inthe 3-month 
followup. In contrast, our study which attempted to assess the impact of 
specific disease related factors associated with the functional status at 
presentation and 6 month functional outcome found that although LETM 
was found to correlate with functional status at admission, it did not have 
any significant association with the functional outcome at 6 months. 
However, quadriparesis and bladder disturbances were found to have 
significant association with functional status at presentation as well as at 
6 month followup.  
 
 
 
 
 
 
CONCLUSION 
1. The spectrum of nontraumatic myelopathy in our study 
population showed equal distribution of compressive as well as 
non-compressive myelopathy. 
2. While the commonest cause of compressive myelopathy was 
cervical spondylotic myelopathy, demyelinating diseases with 
acute transverse myelitis presentation was the most common 
cause of non-compressive myelopathy.  
3. The most common location for cord lesion was in the cervical 
cord based on radiological evaluation. 
4. Significant number of patients remained static in their functional 
status at the end of 6 months. 
5. Quadriparesis and bladder symptoms at initial presentation 
significantly showed association with the 6-month functional 
outcome, whereas LETM lesions on MRI showed significant 
association with the functional status at first presentation.   
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PROFORMA 
 
“A STUDY OF THE CLINICAL SPECTRUM AND FUNCTIONAL 
OUTCOME OF PATIENTS WITH NONTRAUMATIC MYELOPATHY” 
 
PATIENT INFORMATION:  
 
SERIAL  NO.  
 
NAME:      AGE ……. YEARS  
 
GENDER: MALE/FEMALE   MIN NO.   OP/IP NO:   
 
ADDRESS:        PHONE NO: 
 
DISTRICT:       OCCUPATION:  
 
SOCIOECONOMIC STATUS:    EDUCATION: 
       
HISTORY & PRESENTATION:  
Primary complaints                Duration (D/W/M/Y) 
1. - 
2. - 
3. - 
4. – 
 Distal weakness      Duration 
o Tripping on toes 
o Difficulty in holding slippers 
o Unaware slippage of chappals 
 Proximal weakness 
o Buckling of knees 
o Difficulty in getting up from squatting 
 Trunk muscle weakness 
o Difficulty in rolling over 
 Neck muscle weakness 
o Difficulty in lifting head above pillow 
 Sensory complaints       Duration Location 
  
o Parasthesias 
o Burning sensation 
o Numbness 
o Loss of hot/cold sensation 
 Bladder and bowel 
o Urgency 
o Urge incontinence 
o Hesistancy 
o Precipitancy 
o Increased frequency 
o Urine retention 
o Painful retention of urine 
 Visual 
o Loss of color vision 
o Transient visual obscuration 
o Night blindness 
o Progressive loss of vision 
 Auditory 
o Tinnitus 
o Loss of hearing 
 Vertebral symptoms 
o Neck pain 
o Low back pain 
o Radiating pain 
o Kyphosis or scoliosis 
 
PAST HISTORY:  
 Trauma 
 Vision loss 
 Radiation exposure 
 Previous similar episodes 
 
ASSOCIATED CONDITIONS:  
 Diarrhea 
 Anemia or blood transfusions 
 Cachexia  
 Previous hypercoagulable episodes 
 
COMORBIDITIES  
DM /Hypertension /CAD /Stroke /Hyperlipidemia /Liver disease /Kidney 
disease/Thyroid disease /Rheumatological illness /Medications for systemic illnesses 
(with duration)/ Others_______ 
 
PERSONAL HISTORY  
Alcoholism /smoking /tobacco chewing/ substance abuse (mention form and type) 
Diet- Vegetarian / Non vegetarian (type and frequency) 
Drinking water source (mention) 
FAMILY HISTORY  
DM /HT / CAD /Hyperlipidemia /similar complaints 
Others________ 
 
EXAMINATION:  
Temperature  
Pulse  
BP mmHg     
Pallor/Icterus/Lymphadenopathy/Clubbing/Pedal oedema 
Carotid bruit  
Peripheral pulsation  
Thyroid swelling  
Neurocutaneous markers  
Facial dysmorphism 
 
CENTRAL NERVOUS SYSTEM:  
HMF: 
Sensorium: GCS: E V M 
Speech  
MMSE:  
Cranial nerves:     Right    Left 
1. Olfactory nerve:  
2. Optic nerve 
3. Extraocular movements: (3,4,6) 
4. Trigeminal nerve: 
5. Facial nerve 
6. Vestibulocochlear nerve: 
7. Glossopharyngeal and vagal nerve 
8. Accesory nerve: 
9. Hypoglossal nerve:  
 
Superficial reflexes     Right   Left 
 Corneal  
 Conjunctival 
 Abdominal 
 Cremasteric 
 Plantar  
 
Spino motor system:   
 Bulk 
 Tone- UL 
 Tone- LL 
Power  Right  Left  
Neck  Flexion   
 Extension   
Shoulder  Abduction   
 Adduction   
 Flexion   
 Extension   
Elbow Flexion   
 Extension   
Wrist  Flexion   
 Extension   
Handgrip     
Hip Abduction   
 Adduction   
 Flexion   
 Extension   
Knee Flexion   
 Extension    
Ankle Flexion   
 Dorsiflexion   
Extensor hallucislongus    
Flexor hallucislongus    
 
Deep tendon reflexes    
Biceps    
Triceps   
Supinator    
Finger flexion   
Wartenburg   
Hoffmans   
Knee (+clonus)   
Ankle (+clonus)   
 
Sensory:      Right    Left 
 Pain 
 Touch 
 Temperature 
 Vibration 
 Position sense 
 Joint sense 
 Rombergs sign 
Cerebellar Signs: 
 
 Hypotonia 
 Nystagmus 
 Titubation 
 Gait  
 Stance ataxia 
 Tandem walking 
 Finger nose incoordination 
 Past pointing 
 Rebound phenomenon 
 Intention tremors 
 Heel knee test 
 
 
 
Meningeal signs:  
 
 
SLR: 
 
 
Others  
 
CVS:  
 
 
RS: 
 
 
ABDOMEN:  
 
 
 
 
BARTHEL INDEX 
 
FEEDING 
0 = unable 
5 = needs help cutting, spreading butter, etc., or requires modified diet 
10 = independent ______ 
BATHING 
0 = dependent 
5 = independent (or in shower) ______ 
GROOMING 
0 = needs to help with personal care 
5 = independent face/hair/teeth/shaving (implements provided) ______ 
DRESSING 
0 = dependent 
5 = needs help but can do about half unaided 
10 = independent (including buttons, zips, laces, etc.) ______ 
BOWELS 
0 = incontinent (or needs to be given enemas) 
5 = occasional accident 
10 = continent ______ 
BLADDER 
0 = incontinent, or catheterized and unable to manage alone 
5 = occasional accident 
10 = continent ______ 
TOILET USE 
0 = dependent 
5 = needs some help, but can do something alone 
10 = independent (on and off, dressing, wiping) ______ 
TRANSFERS (BED TO CHAIR AND BACK) 
0 = unable, no sitting balance 
5 = major help (one or two people, physical), can sit 
10 = minor help (verbal or physical) 
15 = independent ______ 
MOBILITY (ON LEVEL SURFACES) 
0 = immobile or < 50 yards 
5 = wheelchair independent, including corners, > 50 yards 
10 = walks with help of one person (verbal or physical) > 50 yards 
15 = independent (but may use any aid; for example, stick) > 50 yards ______ 
STAIRS 
0 = unable 
5 = needs help (verbal, physical, carrying aid) 
10 = independent ______ 
Date: _____________________      TOTAL (0–100): ______ 
Follow up date: ____________      TOTAL (0–100): ______ 
 
MODIFIED RANKIN SCALE 
Score Description 
0 No symptoms at all 
1 No significant disability despite symptoms; able to carry out all usual duties and activities 
2 Slight disability; unable to carry out all previous activities, but able to look after own affairs 
without assistance 
3 Moderate disability; requiring some help, but able to walk without assistance 
4 Moderately severe disability; unable to walk without assistance and unable to attend to own bodily 
needs without assistance 
5 Severe disability; bedridden, incontinent and requiring constant nursing care and attention 
6 Dead 
Date: ___________________________ TOTAL (0–6): _______ 
Follow up date: ___________________  TOTAL (0–6): _______ 
 
LAB INVESTIGATIONS  
 
Hb %    gm% / PCV 
TC / DC  
ESR  
Platelets  
Peripheral smear 
 
Mantoux 
 
Blood sugar  
 
Blood urea /Serum creatinine 
Serum electrolytes  
 
Liver function test 
 
ECG 
 
X ray Chest  
 
X-Ray Spine 
 
USG Abdomen 
 
Thyroid profile 
 
Serum Vitamin B12 levels 
 
Serum homocysteine levels 
 
Bone marrow examination 
 
Upper GI endoscopy 
 
Antral biopsy 
 
Serum copper levels 
 
ANA/ds DNA 
c-ANCA/ p-ANCA 
ACL-IgG/IgM 
Lupus anticoagulant 
HIV 
 
VDRL 
 Serum ACE levels 
 
Nerve conduction studies for associated neuropathy  
 
Evoked potentials 
 
CSF: 
 Cell count 
 Cytology 
 Protein 
 Sugar 
 VDRL 
 Gram stain 
 AFB 
 Oligoclonal bands 
 
MRI SPINE: 
 
 
FINAL DIAGNOSIS: 
  
ACUTE/SUBACUTE/CHRONIC 
 
COMPRESSIVE/NONCOMPRESSIVE 
 
CERVICAL/THORACIC/LUMBAR/SACRAL 
 
COMPLICATIONS, IF ANY 
 
ETIOLOGY DETERMINED 
 
 
 
 
 

 

 KEYS FOR MASTER CHART 
Sex  1= Male; 2= Female 
Onset  1= Acute; 2= Subacute; 3= Chronic 
Weakness 
pattern  
1= None; 2= Crural monoparesis; 3= Paraparesis; 4= Quadriparesis; 5= 
Brachial monoparesis  
Weakness 
location 
1= None; 2= Distal predominant; 3= Proximal, 4= Both distal and 
proximal 
Pattern of 
sensory loss 
1= None; 2= Glove and stocking pattern; 3=  Funicular; 4= 
Mononeuritis distribution; 5= Radicular pattern; 6= Hemisensory; 7= 
Definite sensory level 
Bowel 
involvement 
1= None; 2= Incontinence; 3= Constipation 
Bladder 
involvement 
1= None; 2= Urgency; 3= Incontinence; 4= Retention; 5= Hesistancy; 
6= Precipitancy; 7= Painful retention; 8= Frequency  
Speech 
involvement 
1= None; 2= Spastic; 3= Cerebellar 
Visual 
symptoms 
1= None; 2= Loss of vision; 3= Night blindness; 4= Progressive 
diminution of vision  
Vertebral 
symptoms 
1= None; 2= Neck pain; 3= Back pain; 4= Radicular pain 
Past history 
1= None; 2= Trauma; 3=  Visual loss; 4= Radiation; 5= Previous 
similar episodes 
Associated 
history 
1= None; 2= Diarrhoea; 3= Anemia or prior transfusions; 4= Cachexia; 
5= Prior hypercoagulable states; 6= Fever  
Co-morbidities 
1= None; 2= Diabetes mellitus; 3= Hypertension; 4= Coronary artery 
disease; 5= Stroke; 6= Hyperlipidemia;7= Liver disease; 8= Kidney 
disease; 9= Thyroid disease; 10= Rheumatological disease; 11= 
Chronic medications; 12= HIV; 13= TB 
Personal history 
1= None; 2= Alcoholism; 3= Smoking; 4= Tobacco use; 5= Substance 
abuse; 6= Exposure to high risk partners 
Family history 
1= None; 2= Diabetes mellitus; 3= Hypertension; 4= Coronary artery 
disease; 5= Hyperlipidemia 6= Similar illness 
Bulk 1= Normal; 2= Reduced; 3= Hypertrophied 
Tone 1= Normal; 2= Hypotonic; 3= Spasticity; 4= Rigidity 
Romberg 1= Negative; 2= Positive; 3= Could not be tested 
Hemogram  1= Normal; 2= Anemia; 3= Bicytopenia 
TB evidence 1= None; 2= Present  
HIV 1= Nonreactive; 2= Reactive 
CSF 
1= Normal; 2= Elevated protein; 3= Decreased sugar; 4= Oligoclonal 
bands; 5= Not done 
MRI spine 1= Normal; 2= Abnormal 
MRI lesion 
location 
1= Cervical; 2= Dorsal; 3= Lumbar; 4= Cervicodorsal; 5= 
Dorsolumbar; 6= No lesions 
LETM 1= Present; 2= Absent 
Associated 
deficits 
1= None; 2= Optic neuropathy; 3= Peripheral neuropathy; 4= 
Cerebellar involvement  
Diagnostic 
classification/ 
NCM 
1= Idiopathic ATM; 2= MS spectrum; 3= NMO spectrum; 4= HIV 
related; 5= B12 deficiency; 6= HSP; 7= TB myeloradiculitis; 8= 
Unclassified; 9= Hirayama 
Diagnostic 
classification/ 
CM 
1= Cervical spondylosis; 2= IVDP; 3= Pott's spine; 4= OPLL; 5= 
Hypertrophic ligamentum flavum; 6= CVJ anomaly; 7= Atlantoaxial 
dislocation; 8= C1-C2 subluxation; 9= Extramedullary SOL; 10= 
Intramedullary SOL; 11= Dural AVM; 12= Metastasis 
Gross 
diagnostic 
subgrouping 
1= ATM/ NCM; 2= Non ATM /NCM; 3= Cervical spondylosis/ CM; 
4= Non cervical spondylosis/ CM 
Intervention 
done 
1= Medical; 2= Surgical 
Treatment 
strategy 
1= Steroids/NCM;  2= Non steroid management/ NCM; 3= 
Surgery/CM; 4= Conservative/ CM 
BI ans mRS 
outcoem 
1= Static; 2= Worse; 3= Improved; 4= Lost to folowup 
LTFW Lost to followup 
 
 
 
 
 
 
 
   
 
